Cargando…
Efficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up: Efficacy of HBV vaccine in those who lost HBsAg
BACKGROUND: The level of HBsAg in some chronic hepatitis B virus (HBV)-infected individuals may decline over time so that it is not detectable in serum. OBJECTIVE: To assess the efficacy of HBV vaccine in those who lost their HBsAg without seroconverssion to anti-HBs antibody. PATIENTS AND METHODS:...
Autores principales: | Taheri, Hassan, Hasanjani Roushan, Mohammad Reza, Soleimani Amiri, Mohammad Jafar, Pouralijan, Mohammad, Bijani, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206677/ https://www.ncbi.nlm.nih.gov/pubmed/22087128 |
Ejemplares similares
-
Broader use of hepatitis B virus vaccine: Efficacy in those who lost hepatitis B surface antigen during follow-up
por: Kumar, Rakesh, et al.
Publicado: (2011) -
Of Those We Have Lost and Those Who Have Saved So Many Others
por: Chorba, Terence
Publicado: (2022) -
Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV
por: Alavian, Seyed Moayed, et al.
Publicado: (2011) -
HBS Ag seroclearance and seroconversion time in Patients with chronic hepatitis B Infection
por: Masrour-Roudsari, Jila, et al.
Publicado: (2020) -
Immune response to hepatitis B vaccine in patients who lost hepatitis B surface antigen during follow up
por: Zacharakis, Georgios, et al.
Publicado: (2011)